Xconomy | San Diego - Business + Technology in the Exponential Economy

Biotech, Drugs, Multiple Sclerosis

biogen

Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder

Luke Timmerman 11/20/09

[Update: 1:55 pm Eastern, 11/20/09] After a bitter standoff earlier this year with billionaire investor Carl Icahn over alleged mismanagement, Cambridge, MA-based Biogen Idec now faces another sharp attack from a major shareholder.

New York-based HealthCor Management, a hedge fund that invests in health and biotech companies, said today in a regulatory filing that Biogen (NASDAQ: BIIB) overpays CEO James Mullen, that his performance has been poor,... Read more »

Synthetic Biology, Industrial Chemicals, Biofuels

Verdezyne logo best

After Re-Engineering Itself, Verdezyne Sets Course to Develop Biofuels and “Green” Industrial Chemicals

Bruce V. Bigelow 11/20/09

After Carlsbad, CA-based Verdezyne disclosed last month that it plans to raise more than $15 million in venture funding, I arranged to sit down with Damien Perriman, the company’s vice president of business development.

As it... Read more »

wwwade, IT, mapping

World Wide Wade

Using Google’s Building Maker to Change the Face of Boston

Wade Roush 11/20/09

When I was in fifth grade, I wanted to be an architect. (I also wanted to be a geneticist, a meteorologist, and an astronaut. I guess I wound up doing the next best thing to all... Read more »

automotive, cleantech, Cutbacks

aptera2e

Futuristic Carmaker Aptera Disputes Internal Rift, Acknowledges Cutbacks

Bruce V. Bigelow 11/19/09

Aptera, the sleek carmaker backed by Google and Idealabs, didn’t respond to my inquiry earlier this week about reports of an internal split in which founders Steve Fambro and Chris Anthony had left the company. But... Read more »

Biofuels, startups, Collaborations

Biofuels

Big Energy Collaborations Seen to Jump-Start Emerging Biofuels Technologies

Bruce V. Bigelow 11/19/09

As startups developing next-generation biofuels emerge in San Diego, Boston, and elsewhere, a business model for rapidly expanding to commercial-scale operations already can be found in the biotech industry, experts said yesterday. The premise of presentations... Read more »

Biotech, Multiple Sclerosis, Drugs

Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore

Luke Timmerman 11/19/09

Roundup, Life Sciences, funding

Isis Extends Timeline on Cholesterol-Lowering Drug, FDA Delays Review of Cadence Pain Reliever, Fate Therapeutics Raises $30 Million, & More San Diego Life Sciences News

Denise Gellene 11/19/09

Marine Technology, innovation, Robotics

San Diego’s Cottage Industry of Marine Technology Innovation

Bruce V. Bigelow 11/18/09

Biotech, cleantech, Research Labs

Biotech Meets Cleantech: GenVault Aims to Deep Six the Laboratory Deep Freeze

Denise Gellene 11/18/09

Biotech, Cholesterol, Drugs

Isis, Genzyme Cholesterol Drug Passes Test, But Investors Get Nervous About Liver Safety

Luke Timmerman 11/17/09
More recent posts More

Xconomist Forum - Insight & Opinion

cleantech, innovation, renewable energy

Growing Green: An Entrepreneur’s Guide to Cleantech Innovation in San Diego

Robert Noble 11/20/09

[Editors note: Architect Robert Noble wrote this article with Glenn Croston]

The San Diego area is the home of numerous cleantech businesses that are developing innovative green cars (Aptera,... Read more »

startups, deals, VC

Negotiating a Better Series A Deal

Sim Simeonov 11/12/09

[Updated 11/18/09, see below] This post is about how to get a better deal from VCs investing in your first round of financing. It is also about how to... Read more »

Economy, Markets, IPOs

Cautious Perspectives on Recovery in the IPO, M&A, and Credit Markets

Taft Kortus 11/12/09

The second half of 2009 provided a good measure of optimism, easing some of the pain investors felt toward the end of 2008 and in early 2009. The stock market has... Read more »

Biotech, Hepatitis C, HIV

Combination Drugs Are The Future for Hepatitis C

Steve Worland 11/3/09

Commentary, Biotech, innovation

Lilly, With New Focus on Innovation (But Not Necessarily Inclusiveness), Opens San Diego Center for Biotech R&D

Bruce V. Bigelow 10/30/09
More Xconomist posts More

San Diego-Area Local Events

December 02

Using Employee Ownership to Build the Company You Want

Burnham Institute, 10905 Road to the Cure, 92121 - 8 am – 11 am
December 03

San Diego Venture Group Dinner and PitchFest

Hyatt Regency La Jolla, 3777 La Jolla Village Drive, 92122 - 5:30 pm – 8:30 pm
December 09

Intellectual Property Do’s and Don’ts for Startups

Procopio law firm, 1917 Palomar Oaks Way, 92011 - 11:30 am – 1 pm
December 10

Trademarks: A Practical Primer for High Tech Executives

Mintz Levin law firm, 3580 Carmel Mountain Rd., 92130 - 8 am – 9:30 am
December 11

San Diego Connect’s 22nd Annual Most Innovative Products Awards

Hilton La Jolla Torrey Pines, 10950 North Torrey Pines Road, 92037 - 11:30 am – 1:30 pm
More events More
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.